Drug Pricing

Is It Safe and Cost-Effective to Import Drugs from Canada?

States are considering importing prescription drugs from Canada, but is it safe, will it save money, and can it be done? Three, easy-to-read infographics explain what state leaders need to know if they’re considering drug importation legislation. First, 40 percent of all drugs sold in the United States are already imported and 80 percent of […]

Read More
  • Utah’s Norman Thurston Takes a Red State Approach to Lower Rx Costs with a Bill to Import Drugs from Canada
    State Health Policy Blog

    For more than a decade, Utah State Legislator and Director of the Office of Health Care Statistics Norman Thurston has worked to reform his state’s health care system, including its Medicaid program, and is considered one of the state’s “go-to” health care policymakers. Thurston, a Republican, has worked to reduce state spending on prescription drugs and […]

    Read More
  • At NASHP’s 30th State Health Policy Conference, state leaders from legislative and executive branches across the nation gathered to talk about what they are doing to manage escalating prescription drug costs in their states. Several states have recently passed or proposed legislation to force more transparency in drug pricing or to try to regulate drug […]

    Read More
    October 24, 2017 | Filed under: 2017 Conference, Drug Pricing, Front Page, Front Page-Rx
  • Lowering Drug Costs: Transparency Legislation Sets Off Flurry of New State Approaches
    State Health Policy Blog

    Responding to rapidly rising drug costs, 30 states across the country have drafted more than 60 drug price transparency bills designed to: Identify the costs that contribute to drug manufacturer expenses and list prices And unveil the often opaque business practices of pharmacy benefit managers (PBMs). In addition to promoting pricing transparency, as of early […]

    Read More
  • State Health Policy Blog

    States are searching for new and innovative approaches to handle the rising cost of prescription medicines – both the sudden spike in spending that comes with a new high-cost treatment and the ongoing challenges of regular, inexplicable, price hikes for all covered drugs. The United States has the highest prescription drug prices in the world. […]

    Read More
  • The National Academy for State Health Policy (NASHP), with support from the Laura and John Arnold Foundation, today launched the Center for State Rx Drug Pricing. Building on the work of NASHP’s Pharmacy Costs Work Group over the past year, the Center will provide technical and strategic assistance to states, leverage legal and actuarial expertise […]

    Read More
    June 20, 2017 | Filed under: Drug Pricing, News & Media, Press Release
  • Wednesday, October 25th 11:00AM-12:30PM States need innovative approaches to manage the rising cost of prescription medicines. The United States has the highest prescription drug prices in the world, which continue to rise at an alarming rate – averaging 10 percent annually since 2013. NASHP convenes state legislators and policy leaders who have taken bold steps […]

    Read More
    June 6, 2017 | Filed under: 2017 Conference, Drug Pricing, Prescription Drugs
  • Monday, October 23rd 12:30PM-3:30PM Register for a half day, state-only summit of state leaders from legislative and executive branches to talk about managing prescription drug costs. Hear from state leaders to learn about what states can and are doing to build support for change and to manage the lobbying and legal counter-efforts of the pharmaceutical industry. […]

    Read More
    June 6, 2017 | Filed under: 2017 Conference, Drug Pricing
  • State Health Policy Blog

    In its May 30, 2017 decision Impression Products, Inc. v Lexmark International Inc., the Supreme Court ruled that patent law cannot be used to prevent the resale of products back into the United States. The Court case specifically concerned printer toner cartridges, but it is an important ruling in the context of the domestic policy […]

    Read More
  • As States Wage Battles on High Drug Prices, Drugmakers Fight Back May 18, 2017 Lembo targets ‘skyrocketing’ drug prices January 24, 2017 How can states tackle rising medication prices? January 11, 2017 Interfaith investor coalition pushes shareholder resolutions on drug prices, October 24, 2016 Politico Pulse mentioned the findings of the Pharmacy Costs Work Group, October 24, 2016 […]

    Read More